Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07574983
Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helicobacter Pylori EradicationUniversity of Health Sciences LahoreNot Yet RecruitingNot Applicable
NCT07574983Not Yet Recruiting
Not Applicable
Levofloxacin-Based Sequential Therapy Versus Bismuth Quadruple Therapy for Helic...University of Health Scie...
NCT07574463
Adaptive Digital Exercise Rehabilitation for Children After CHD SurgeryBeijing Children's HospitalNot Yet RecruitingNot Applicable
NCT07574463Not Yet Recruiting
Not Applicable
Adaptive Digital Exercise Rehabilitation for Children After CHD SurgeryBeijing Children's Hospit...
NCT07575880
Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care PathwayCentre Hospitalier de la côte BasqueNot Yet Recruiting
NCT07575880Not Yet Recruiting
—
Screening for Obstructive Respiratory Disorders in the General Population During...Centre Hospitalier de la...
NCT07575581
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul UniversityCompleted
NCT07575581Completed
—
Psychometric Evaluation of the EVARUCI Scale in Turkish Intensive Care UnitsIstanbul University
NCT07576036
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of HyponatremiaRochester General HospitalEnrolling By Invitation
NCT07576036Enrolling By Invitation
—
International Multi-center Retrospective Study of Patients With Serum Sodium ≤11...Rochester General Hospita...
NCT07576621
Association Between Hypomagnesemia and Coagulopathy in SepsisAin Shams UniversityCompleted
NCT07576621Completed
—
Association Between Hypomagnesemia and Coagulopathy in SepsisAin Shams University
NCT07576699
CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)Cellenkos, Inc.Not Yet RecruitingPhase 1
NCT07576699Not Yet Recruiting
Phase 1
CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)Cellenkos, Inc.
NCT07576972
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576972Not Yet Recruiting
Not Applicable
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Med...
NCT07575841
Pulmonary Rehabilitation Frequency in COPD PatientsHospital Universitario Fundación AlcorcónNot Yet RecruitingNot Applicable
NCT07575841Not Yet Recruiting
Not Applicable
Pulmonary Rehabilitation Frequency in COPD PatientsHospital Universitario Fu...
NCT07574450
Taiwan ED Airway Quality Surveillance Registry (TEAR)Chang Gung Memorial HospitalNot Yet Recruiting
NCT07574450Not Yet Recruiting
—
Taiwan ED Airway Quality Surveillance Registry (TEAR)Chang Gung Memorial Hospi...
NCT07576933
Effects of Two Intervention Programs on Physical Fitness and Quality of Life Among People With Intellectual DisabilitiesUniversidad Católica San Antonio de MurciaEnrolling By InvitationNot Applicable
NCT07576933Enrolling By Invitation
Not Applicable
Effects of Two Intervention Programs on Physical Fitness and Quality of Life Amo...Universidad Católica San...
NCT07575737
The Impact of Preoperative Statin Therapy and and Its Intensity on Postoperative and Mortality and MorbidityKarolinska InstitutetCompleted
NCT07575737Completed
—
The Impact of Preoperative Statin Therapy and and Its Intensity on Postoperative...Karolinska Institutet
NCT07574710
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability in Immediate Implant Placement: A Clinical Study With 1-Year Post-Restorative ResultsTomas LinkeviciusCompletedNot Applicable
NCT07574710Completed
Not Applicable
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability...Tomas Linkevicius
NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sahlgrenska University HospitalNot Yet RecruitingPhase 2
NCT07576257Not Yet Recruiting
Phase 2
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili...Sahlgrenska University Ho...
NCT07575555
The Effect of Lipedema on Knee OsteoarthritisIzmir Democracy UniversityNot Yet Recruiting
NCT07575555Not Yet Recruiting
—
The Effect of Lipedema on Knee OsteoarthritisIzmir Democracy Universit...
NCT07575542
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational Tennis Players With MechanicalIstinye UniversityCompletedNot Applicable
NCT07575542Completed
Not Applicable
The Effects of Spinal Mobilization Added to an Exercise Program in Recreational...Istinye University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07575893
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering Cancer CenterNot Yet RecruitingPhase 1
NCT07575893Not Yet Recruiting
Phase 1
CD30 CAR-T Cells for Low Risk Relapsed Classical Hodgkin LymphomaMemorial Sloan Kettering...
NCT07574645
Spinal Dural Arteriovenous Fistula International Data and Outcomes RegistryThomas Jefferson UniversityRecruiting
NCT07574645Recruiting
—
Spinal Dural Arteriovenous Fistula International Data and Outcomes RegistryThomas Jefferson Universi...
NCT07575308
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMBAlnylam PharmaceuticalsNot Yet RecruitingPhase 2
NCT07575308Not Yet Recruiting
Phase 2
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Pa...Alnylam Pharmaceuticals
Result Breakdown
Not yet recruiting12 (60%)
Completed5 (25%)
Enrolling by invitation2 (10%)
Recruiting1 (5%)
not_applicable8 (40%)
Not Specified8 (40%)
Phase 12 (10%)
Phase 22 (10%)